ARCHIVES

CMS also decided to cover off-label uses of approved colorectal cancer drugs in clinical trials, and allowed broader use of PET scans.

This article is from The Cancer Letter archive.

Vol. 30 No. 42 | November 5, 2004

Download PDF Visit The Full Archive

Related Articles

DCPC Board Okays Start of Low Fat High Risk Breast Cancer Study, Delays Stage 2 Trial

February 1, 1985

Report Redefines Cancer Control Research, Sets the Agenda For Newest NCI Division

October 17, 1997

ASCO Teleconference Set For Nov. 12

October 31, 1986

New Drug for Lymphoma Enters Phase II Trial

May 28, 2004

Reports: Tobacco Cessation Underused, NIH Panel Says.

June 16, 2006

CGAP Speeding Gene Discovery

April 30, 1999